Methodology

All entries for: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd

January 15, 2026

XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd

Orphan Drug Designation

treatment of malignant glioma

Disease Area: Rare Disease
Source
Source
Scroll to Top